Modified citrus pectin – developed from the skin of citrus fruits – could act as a potent anti-cancer therapy, a new
research has found.
Researchers at the University of Maryland School of Medicine highlighted a large body of published research demonstrating how modified citrus pectin
(MCP), works against cancer, daily mail reported here.
“This review does an excellent job consolidating our knowledge about modified citrus pectin’s remarkable therapeutic impact,” said Isaac Eliaz, integrative medicine researcher and MCP co-developer.
“In particular, it identifies MCP’s different mechanisms of action against metastatic cancer, heavy metal toxicity and chronic, life threatening illnesses related to excess galectin-3,” Eliaz said.
While plant pectins have long been known to support digestive and immune health through their actions in the GI tract, the main obstacle preventing them from exerting systemic benefits in the body has been their bio-availability.
The long complex soluble fibers in regular pectin are simply too large to be absorbed into the circulation. This problem was solved with the development
of MCP, which is prepared from regular citrus pectin using a modification
process to reduce the size and cross branching of the pectin molecules.
0 comments:
Post a Comment